Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
A Phase I/IIa Randomized, Double-Blind, Vehicle-Controlled Clinical Trial with Separate
Open-Label Active Treatment Phase Evaluating the Safety, Pharmacokinetics and Efficacy of
FMX114 Gel in the Treatment of Mild-to-Moderate Atopic Dermatitis in Adults